- Home
- ACN vs BSX Comparison
ACN vs BSX Comparison
Compare ACN & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACN | BSX |
|---|---|---|
| Founded | 1989 | 1979 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.6B | 137.8B |
| IPO Year | N/A | 1992 |
Fundamental Metrics
Financial Performance| Metric | ACN | BSX |
|---|---|---|
| Price | $268.61 | $95.51 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 22 | 17 |
| Target Price | ★ $302.05 | $125.88 |
| AVG Volume (30 Days) | 3.8M | ★ 9.3M |
| Earning Date | 12-18-2025 | 02-04-2026 |
| Dividend Yield | ★ 2.43% | N/A |
| EPS Growth | 1.33 | ★ 54.68 |
| EPS | ★ 12.09 | 1.87 |
| Revenue | ★ $70,725,557,000.00 | $19,349,000,000.00 |
| Revenue This Year | $6.90 | $21.05 |
| Revenue Next Year | $5.39 | $11.44 |
| P/E Ratio | ★ $22.20 | $50.99 |
| Revenue Growth | 6.58 | ★ 21.61 |
| 52 Week Low | $229.40 | $85.98 |
| 52 Week High | $398.35 | $109.50 |
Technical Indicators
Market Signals| Indicator | ACN | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 55.44 | 46.31 |
| Support Level | $269.50 | $95.55 |
| Resistance Level | $273.27 | $96.64 |
| Average True Range (ATR) | 5.20 | 1.50 |
| MACD | -1.09 | 0.33 |
| Stochastic Oscillator | 37.95 | 75.18 |
Price Performance
Historical ComparisonAbout ACN Accenture plc (Ireland)
Accenture is a leading IT services firm that provides consulting, system integration, and business process outsourcing to enterprises around the world. Customers of Accenture come from a variety of sectors, including communications, media and technology, financial services, health and public services, consumer products, and resources. Accenture is the world's largest professional services company by headcount with around 800,000 employees in over 120 countries.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.